‘October is coming,’ and everyone still wants to know if a Covid-19 vaccine will be whisked through the FDA ahead of the election – Endpoints News

By CEO and scion Adar Poonawallas estimation, the Serum Institute in India has already poured hundreds of millions of dollars into scaling up the unproven Covid-19 vaccine being developed by AstraZeneca and Oxford for use in low and middle income countries. Its meant taking on a risk that other companies, including AstraZeneca, have mitigated with huge amounts of government funding.

Now, for the first time, Poonawalla is getting some outside help. The Gates Foundation has agreed to pay the institute $150 million to supply 100 million vaccines to India and other emerging economies next year,Reutersreported. That includes both the vaccine being developed by AstraZeneca and the one being developed by Novavax. Those vaccines will be available in 92 countries and be priced at $3 per dose.

Unlock this story instantly and join 86,700+ biopharma pros reading Endpoints daily and it's free.

SUBSCRIBE SIGN IN

View post:

'October is coming,' and everyone still wants to know if a Covid-19 vaccine will be whisked through the FDA ahead of the election - Endpoints News

Related Posts
Tags: